These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 1000516
1. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia. Schmid FA, Hutchison DJ, Otter GM, Stock CC. Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516 [Abstract] [Full Text] [Related]
2. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations. Kim K, Blechman WJ, Riddle VG, Pardee AB. Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006 [Abstract] [Full Text] [Related]
3. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT, Johnson RK, Kline I, Vadlamudi S, Gang M, Venditti JM, Goldin A. Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [Abstract] [Full Text] [Related]
4. Single versus combination chemotherapy of L1210 leukemia. Koza I, Balázová E, Ujházy V. Neoplasma; 1980 Sep; 27(6):691-6. PubMed ID: 7254424 [Abstract] [Full Text] [Related]
5. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites. Fujimoto S, Ogawa M, Hoshino A. Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770 [Abstract] [Full Text] [Related]
7. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine. Kataoka T, Akahori Y, Sakurai Y. Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896 [Abstract] [Full Text] [Related]
8. [Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside]. Bukhman VM, Lichinitser MR, Svet-Moldavskiĭ GIa, Mkheidze DM. Biull Eksp Biol Med; 1978 Mar; 85(3):340-3. PubMed ID: 276385 [Abstract] [Full Text] [Related]
9. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia. Chello PL, Sirotnak FM. Cancer Treat Rep; 1981 Mar; 65(11-12):1049-53. PubMed ID: 7296551 [Abstract] [Full Text] [Related]
10. Effect of thymidine on the toxicity and antitumor activity of ftorafur. Grossie VB, Loo TL. Cancer Treat Rep; 1981 Mar; 65(11-12):1087-91. PubMed ID: 6794908 [Abstract] [Full Text] [Related]
14. Combined effect of cytosine arabinoside and thiopurines. Valeriote F, Vietti T, Edelstein M. Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347 [Abstract] [Full Text] [Related]
15. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models. Breistøl K, Balzarini J, Sandvold ML, Myhren F, Martinsen M, De Clercq E, Fodstad O. Cancer Res; 1999 Jun 15; 59(12):2944-9. PubMed ID: 10383159 [Abstract] [Full Text] [Related]
16. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA, Sirotnak FM, Otter GM, DeGraw JI. Cancer Treat Rep; 1987 Jun 15; 71(7-8):727-32. PubMed ID: 3607784 [Abstract] [Full Text] [Related]
17. Combined therapy of L1210 leukemia with Damvar and cytostatics. Pujman V, Cernochová S. Neoplasma; 1979 Jun 15; 26(5):521-3. PubMed ID: 522924 [Abstract] [Full Text] [Related]
20. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents]. Ninomiya K, Sekido S, Araki T. Gan To Kagaku Ryoho; 1984 Jun 15; 11(6):1315-23. PubMed ID: 6428326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]